Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🚫 This provider appears on the OIG List of Excluded Individuals/Entities (LEIE)
Exclusion type: 1128b7 · Date: 09/15/2023 · State: NY
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
245
Total Claims
$6,227
Drug Cost
25
Beneficiaries
$249
Cost/Patient
Risk Score Breakdown 20/100
Score components are additive. Read full methodology
Peer Comparison vs. 18,720 Cardiology providers
-84%
Cost per patient vs peers
$249 vs $1,524 avg
-43%
Brand preference vs peers
7.8% vs 13.7% avg
🔎 Data Overview
This provider appears on the federal OIG exclusion list, meaning they have been formally barred from participating in federal healthcare programs due to fraud, patient abuse, licensing issues, or other misconduct. The fact that they still appear in active prescribing data is a significant concern.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Brand vs Generic
Brand: 19 claims · $3,004
Generic: 226 claims · $3,223
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Losartan/Hydrochlorothiazide | 22 | $457 |
| Rosuvastatin Calcium | 20 | $306 |
| Metoprolol Succinate | 29 | $296 |
| Atorvastatin Calcium | 20 | $292 |
| Carvedilol | 13 | $241 |
| Losartan Potassium | 33 | $229 |
| Clopidogrel Bisulfate | 13 | $221 |
| Amlodipine Besylate | 14 | $120 |
Prescribing Profile
8
Unique Drugs
20.0
Anomaly Score
Patient Profile
74
Avg Age
48%
Female
1.26
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data